Table 4 30-days survival
30-days survival; n (%) | |||
|---|---|---|---|
Parameter | LS + n = 82 | LS - n = 155 | p-value |
All patients n = 237 | 69/82 (84) | 123/155 (79) | 0.40 |
Subgroup: procedural categories | |||
Isolated CABG | 26/32 (81) | 58/68 (85) | 0.77 |
Isolated valve surgery / ascending aortic surgery | 11/12 (92) | 23/33 (70) | 0.24 |
Combination procedures | 32/38 (84) | 42/54 (78) | 0.64 |
Subgroup analysis: renal impairment | |||
GFR >120ml/min. | 32/35 (91) | 50/59 (85) | 0.53 |
GFR 85–120ml/min. | 12/13 (92) | 47/55 (86) | 1.00 |
GFR 51–85 ml/min. | 17/20 (85) | 19/29 (66) | 0.19 |
GFR < 51ml/min. | 5/9 (56) | 4/7 (57) | 1.00 |
Dialysis | 3/5 (60) | 3/5 (60) | 1.00 |
Subgroup analysis: preoperative LVEF | |||
LVEF <25% | 29/36 (81) | 46/65 (71) | 0.34 |
LVEF 25–30% | 21/23 (91) | 41/48 (85) | 0.60 |
LVEF 31–35% | 19/23 (83) | 36/42 (86) | 0.72 |
Subgroup analysis: EuroSCORE II | |||
EuroSCORE II <15 | 37/39 (95) | 84/91 (92) | 0.72 |
EuroSCORE II 15–17 | 3/4 (75) | 4/5 (80) | 1.00 |
EuroSCORE II 18–20 | 2/2 (100) | 4/5 (80) | 1.00 |
EuroSCORE II 21–23 | 4/5 (80) | 3/3 (100) | 1.00 |
EuroSCORE II >23 | 16/23 (70) | 20/39 (51) | 0.19 |
Subgroup analysis: Recent myocardial infarction | |||
No recent myocardial infarction | 50/55 (91) | 72/87 (83) | 0.22 |
Recent myocardial infarction | 19/27 (70) | 51/68 (75) | 0.80 |